Vivo Capital »

Q32 Bio shares owned by Vivo Capital

Quarter-by-quarter ownership of Q32 Bio shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by Vivo Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.3M 370k 17.04

More positions owned by Vivo Capital

Soleno Therapeutics Common (SLNO)
Geron Corp Common (GERN)
Harmony Biosciences Holdings Common (HRMY)
Sinovac Biotech SHS (SVA)
Avadel Pharmaceuticals Adr (AVDL)
Verona Pharma Sponsored Ads (VRNA)
ALX Oncology Holdings Common (ALXO)
Dyne Therapeutics Common (DYN)
Terns Pharmaceuticals Common (TERN)
Astria Therapeutics Common (ATXS)
Viridian Therapeutics Common (VRDN)
Silence Therapeutics Ads (SLN)
Olema Pharmaceuticals Common (OLMA)
Adverum Biotechnologies Common
Alpine Immune Sciences Common (ALPN)

View all positions for Vivo Capital

Top funds holding Q32 Bio

Atlas Venture Life Science Advisors
Carlyle
Vivo Capital
Vanguard Group
BML Capital Management
Acadian Asset Management
Wells Fargo & Company
Rhumbline Advisers
AdvisorNet Financial
Advisor Group Holdings
BFSG
Thompson Investment Management

View all funds holding Q32 Bio